Tiny trial tests catheter fix for leaky heart valves
NCT ID NCT07188233
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This early study is testing a new device called CathHELIX that aims to repair a leaky mitral valve using a thin tube (catheter) instead of open-heart surgery. The trial will enroll just 5 people with moderate to severe mitral regurgitation who have symptoms like shortness of breath. The main goal is to see if the device can be safely placed and work as intended.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- CathHELIX Transcatheter Mitral Annuloplasty System (a device)
- What this could lead to
- If successful, this could offer a less invasive repair option for people with leaky mitral valves, potentially reducing symptoms and improving heart function.
- What could go wrong
- This is a very early feasibility study with only 5 people. The device may not work as intended, and risks include complications from the procedure or the need for emergency surgery.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MITRAL VALVE REGURGITATION (DEGENERATIVE OR FUNCTIONAL) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Tbilisi Heart and Vascular Clinic
RECRUITINGTbilisi, Georgia, Georgia
-
Vilnius University Hospital, Santaros Klinikos, Public Institution
RECRUITINGVilnius, Lithuania, Lithuania
More trials for these conditions
Other studies related to the condition(s) this trial covers.